The United States Milbemycin Oxime Market size is reached a valuation of USD xx.x Billion in 2023, with projections to achieve USD xx.x Billion by 2031, demonstrating a compound annual growth rate (CAGR) of xx.x% from 2024 to 2031.
United States Milbemycin Oxime Market By Application
- Dogs
- Cats
- Cattle
- Sheep
- Horses
The United States market for milbemycin oxime is segmented by application into several key segments. Firstly, in the context of companion animals, the use of milbemycin oxime is prominently seen in treating parasitic infections in dogs and cats. This segment is driven by the high incidence of heartworm and other intestinal parasites in domestic pets, necessitating regular preventive treatments.
Secondly, in the livestock sector, milbemycin oxime finds application primarily in cattle, sheep, and horses. These animals are susceptible to various parasitic infections, and milbemycin oxime formulations offer effective solutions for deworming and parasite control. The market growth in these segments is bolstered by the increasing emphasis on animal health and welfare, driving demand for effective parasiticides.